Standard Biotools (LAB) Change in Acquisitions & Divestments (2011 - 2026)

Standard Biotools (LAB) has 14 years of Change in Acquisitions & Divestments data on file, last reported at $15.0 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 71.15% year-over-year to $15.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $142.0 million (down 50.87% YoY) and the FY2025 annual result came in at $179.0 million, down 48.71% from the prior year.
• Change in Acquisitions & Divestments eased to $15.0 million in Q1 2026 per LAB's latest filing, from $25.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $127.0 million in Q2 2024 and bottomed at $12.0 million in Q3 2022.
• The 5-year median for Change in Acquisitions & Divestments is $49.0 million (2024), against an average of $51.0 million.
• The widest annual swing landed in 2024, when Change in Acquisitions & Divestments jumped 210.03%; it then slumped 71.15% in 2026.
• Tracing LAB's Change in Acquisitions & Divestments over 5 years: stood at $41.0 million in 2022, then slumped by 36.59% to $26.0 million in 2023, then jumped by 130.77% to $60.0 million in 2024, then plunged by 58.33% to $25.0 million in 2025, then slumped by 40.0% to $15.0 million in 2026.
• Per Business Quant, the three latest LAB Change in Acquisitions & Divestments figures stand at $15.0 million (Q1 2026), $25.0 million (Q4 2025), and $54.0 million (Q3 2025).

Peer Comparison